BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36048530)

  • 1. Genetic Polymorphism in Toll-Like Receptor 3 and Interferon Regulatory Factor 3 in Hepatitis C Virus-Infected Patients: Correlation with Liver Cirrhosis.
    Talaat RM; Elsayed SS; Abdel-Hakem NE; El-Shenawy SZ
    Viral Immunol; 2022 Nov; 35(9):609-615. PubMed ID: 36048530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
    Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.
    Studzińska M; Jabłońska A; Wiśniewska-Ligier M; Nowakowska D; Gaj Z; Leśnikowski ZJ; Woźniakowska-Gęsicka T; Wilczyński J; Paradowska E
    PLoS One; 2017; 12(1):e0169420. PubMed ID: 28046022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    Sheneef A; Esmat MM; Mohammad AN; Mahmoud AA; Moghazy HM; Noureldin AK
    J Interferon Cytokine Res; 2017 Apr; 37(4):175-180. PubMed ID: 28387594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers.
    Abdelwahab SF; Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I
    Clin Exp Immunol; 2021 Jan; 203(1):3-12. PubMed ID: 32939755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan.
    Nurlanova G; Zhumagaliyeva G; Iskakova A; Astrakhanov A; Kurmangazin M
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3925-3930. PubMed ID: 38019252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
    Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
    Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
    Lee SO; Brown RA; Razonable RR
    Transpl Infect Dis; 2013 Apr; 15(2):111-9. PubMed ID: 23240626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.
    Zayed RA; Omran D; Mokhtar DA; Zakaria Z; Ezzat S; Soliman MA; Mobarak L; El-Sweesy H; Emam G
    Am J Trop Med Hyg; 2017 Mar; 96(3):720-726. PubMed ID: 28093541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis.
    Talaat RM; Elsharnoby S; Abdelkhalek MS; El-Shenawy SZ; Elmasry S
    Immunol Invest; 2022 Apr; 51(3):688-704. PubMed ID: 33445993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection.
    El-Bendary M; Neamatallah M; Elalfy H; Besheer T; Elkholi A; El-Diasty M; Elsareef M; Zahran M; El-Aarag B; Gomaa A; Elhammady D; El-Setouhy M; Hegazy A; Esmat G
    Br J Biomed Sci; 2018 Oct; 75(4):175-181. PubMed ID: 29947302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients.
    Nischalke HD; Berger C; Luda C; Müller T; Berg T; Coenen M; Krämer B; Körner C; Trebicka J; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U
    J Hepatol; 2012 Apr; 56(4):758-64. PubMed ID: 22173151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
    Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
    J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
    Askar E; Bregadze R; Mertens J; Schweyer S; Rosenberger A; Ramadori G; Mihm S
    J Med Virol; 2009 Jul; 81(7):1204-11. PubMed ID: 19475618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes.
    Wei D; Li NL; Zeng Y; Liu B; Kumthip K; Wang TT; Huo D; Ingels JF; Lu L; Shang J; Li K
    J Biol Chem; 2016 Jun; 291(23):12294-309. PubMed ID: 27129228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
    El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
    J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.